Ligand Pharmaceuticals LGND Tax on Share Settlement
Tax on Share Settlement at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's tax on share settlement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's tax on share settlement?
- Ligand Pharmaceuticals (LGND) reported tax on share settlement of $21.73M in Q1 2026.
- How has Ligand Pharmaceuticals's tax on share settlement changed year-over-year?
- Ligand Pharmaceuticals's tax on share settlement increased by 144.4% year-over-year, from $8.89M to $21.73M.
- What is the long-term trend for Ligand Pharmaceuticals's tax on share settlement?
- Over 4 years (2021 to 2025), Ligand Pharmaceuticals's tax on share settlement has grown at a 12.4% compound annual growth rate (CAGR), from $6.02M to $9.6M.
- What does tax on share settlement mean?
- Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.